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Introduction
The European Commission is taking a cross-cutting look at the 
approach to the assessment and management of endocrine 
disruptors (EDs) in a broad range of legislation through what 
is described as a Fitness Check1. The goal is to analyse the 
coherence of the different approaches to this topic, identify 
possible gaps and synergies, and assess their collective impact 
on human health and the environment.
Public consultation is an essential component of the Fitness 
Check. It aims at gathering inputs from citizens to ensure 
that views from all interested parties are considered in the 
evaluation. This ED Fitness Check includes three consultations, 
a public consultation (designed from a citizen’s perspective) 
a stakeholder consultation (designed for stakeholders and 
experts) and a consultation to collect the views of micro, small 
and medium-sized enterprises (SMEs).
The aims of this public consultation targeting the general public 
were:
• To assess public concerns and needs with respect to endocrine 
disruptors in the EU.
• To evaluate to what extent current EU legislation meets the 
concerns and needs of citizens.
• To identify opportunities for improvement in the way endocrine 
disruptors are assessed, managed and potential risks communicated.
The consultation was conducted through the European 
Commission’s ‘Have your Say’ Better Regulation webportal and 
was open from 16/12/2019 to 09/03/2020.
1 https://ec.europa.eu/info/law/better-regulation/have-your-say/
initiatives/2142-Fitness-Check-on-endocrine-disruptors
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This summary report provides a brief factual overview of the 
replies received, with information on the respondents as well 
as the number of responses and range of opinions. The replies 
gathered through the consultation will help the European 
Commission to understand the views and perceptions of the 
general public on the issue of endocrine disruptors and will make 
an important contribution to the Fitness Check of the current 
legislation. A more detailed analysis of the responses to all three 
consultations will be published in a synopsis report at the end 
of the process.
PART 2.
Who responded to the survey
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Respondents
A total of 474 respondents provided an answer, of which 90% 
are EU citizens, 3% are academic/research institutions and 2% 
non-governmental organisations.
As regards the origin of the respondents participating to the 
survey, we received most answers from France (40%), Germany 
(17%), Spain (14%), Belgium (5%) and Finland (5%).
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PART 3.
What did the respondents say?
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Information on endocrine disruptors
A majority of the respondents consider themselves to be very 
well informed (14%) or reasonably well informed (49%) about 
endocrine disruptors, as opposed to feeling poorly informed 
(31%) or not informed at all (6%).
The main sources of information on endocrine disruptors used by 
the respondents are specialised scientific sources (246), general 
news coverage (222), social media (178), education and training 
sources (131) and other sources (118).  
A majority of the respondents feel informed about the decisions 
made in the EU with regard to endocrine disruptors (11% very 
well informed; 57% somewhat informed). A minority (21%) do 
not feel informed, but trust regulators to keep them safe, while 
11% replied that they do not know.
Fifty-four percent of the respondents do not think that the 
effects on endocrine disruptors on public health and the 
environment are understood and 38% think the effects are 
understood to a certain extent as opposed to 5% that think 
effects are not understood.
Effectiveness of EU laws
As presented in the next figure, the majority of respondents (58% 
to 73%) considered that EU laws did not protect them at all or 
only to a small extent from exposure to endocrine disruptors 
across all of the potential exposure sources listed in the survey. 
The four exposure sources where respondents consider that EU 
laws protect them the least are clothing, electric and electronic 
equipment, detergents and outdoor air.
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Sixty-one percent of the respondents consider that they are less 
protected by EU laws from endocrine disruptors than from other 
toxic chemicals, such as carcinogenic or mutagenic substances, 
or substances toxic to reproduction with 20% considering that 
they are protected to the same extent.
As presented in the figure below, in general, over 60% of 
respondents consider that EU laws offer a low level of 
protection for one or more life stages with the highest number 
of respondents concerned about adolescents (75%) and the 
lowest numbers concerned about pregnant women, foetuses 
and newborns (62% to 66%).
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THE ENDOCRINE (HORMONAL) SYSTEM CONTROLS A LARGE NUMBER OF PROCESSES IN 
THE BODY THROUGHOUT LIFE FROM EARLY STAGES SUCH AS EMBRYONIC DEVELOPMENT 
AND PUBERTY, TO LATER ONES SUCH AS REPRODUCTIVE LIFE AND OLD AGE. 
CONSIDERING DIFFERENT LIFE STAGES, IN YOUR OPINION HOW WELL DO EU LAWS 
PROTECT CITIZENS FROM EFFECTS OF ENDOCRINE DISRUPTORS?
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Ninety-three percent of respondents believe that endocrine 
disruptors contribute to a large or moderate extent to some 
human diseases or health conditions such as infertility, cancer 
or obesity.
From 72% to 81% of respondents consider that EU laws offer a 
low level of protection for wildlife such as insects, including bees 
and other pollinators (81%), fish and amphibians (80%), other 
invertebrates, such as snails, shrimps or worms (79%), birds and 
reptiles (76%), mammals (74%) and plants (72%).
A majority of respondents expressed the view that the EU 
should have the same approach or the same approach to the 
extent possible across regulatory sectors for both identifying 
endocrine disruptors (86%) and managing the risks of exposure 
to endocrine disruptors (84%).
Many of the respondents are of the opinion that endocrine 
disruptors are insufficiently identified across a range of sectors, 
particularly in furnishing and electrical and electronic equipment 
(see next figure).
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As presented in the figure below, the majority of respondents are 
also of the opinion that EU laws insufficiently manage the risks 
linked to endocrine disruptors across all sectors. For example, the 
number of respondents considering that endocrine disruptors are 
not well managed in the pesticide sector is 73% compared with 
15% who think endocrine disruptors are well managed or fairly 
well managed and 12% who do not know or did not reply. For 
medical devices, 53% of respondents consider that endocrine 
disruptors are not well managed compared with 22% who think 
that they are well managed or fairly well managed and 25% 
who do not know or did not reply.
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Regulatory testing and animal welfare
Thirty-seven percent of the respondents think that animal testing 
for endocrine disrupting properties in the EU is insufficiently 
minimised, whereas 28% consider animal testing to be fully 
minimised (5%) or minimised to the extent possible (23%). 
Thirty-five percent replied that they do not know.
Efficiency of EU laws
Forty-four percent of the respondents consider that the costs 
(e.g. time, resources, use of laboratory animals) of EU laws on 
endocrine disruptors are proportionate for the benefits accrued 
compared with 26% who consider costs are only to a small 
extent or not at all proportionate. Thirty percent replied that they 
do not know.
In general, the respondents consider that EU laws on endocrine 
disruptors generate slightly more costs for the agricultural and 
industrial sectors compared with costs to citizens or ethical costs 
(see next figure).
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As illustrated in the figure below, EU laws on endocrine disruptors 
are believed to generate benefits for the EU market by about half 
of the respondents (49% agree fully or to a moderate extent, 
while 24% agree to a small extent or don’t agree at all and 27% 
don’t know or didn’t reply). Opinion is also divided on the extent 
to which EU laws on endocrine disruptors are seen to benefit 
human health and wildlife. 
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Added value of EU laws
In terms of which bodies should regulate to protect people 
and wildlife from harm caused by endocrine disruptors, most 
respondents expressed the view that this should be done by 
EU authorities (432), and many respondents considered that 
national authorities (356), international organisations (292) and 
local/regional authorities (238) should act.
For this question, the numbers of respondents are given, rather 
the percentage values, since it was possible to select more than 
one option. The breakdown of responses (based on the number of 
choices chosen by respondents) is given in the following diagram.
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IN YOUR OPINION, WHO SHOULD REGULATE TO PROTECT PEOPLE AND WILDLIFE 
FROM HARM CAUSED BY ENDOCRINE DISRUPTORS? 
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Relevance of EU laws
In terms of areas where the EU needs to significantly step up its 
efforts, the respondents prioritised as follows: reducing exposure 
of humans (88%), reducing exposure to wildlife (84%), identifying 
endocrine disruptors (80%), and adopting a coherent approach 
to identification and management of endocrine disruptors (79%). 
Fewer respondents consider that a lot of efforts are needed by 
the EU to reduce the burdens and costs to business (30%).
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